Capital International Inc’s Ascendis Pharma A/S ASND Stock Holding History

Capital International Inc’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79M	Buy	10,443 +50	+0.5%	+$11.7K	0.02%	261
2026 Q1	$2.38M	Buy	10,393 +1,328	+15%	+$298K	0.02%	263
2025 Q4	$1.93M	Sell	9,065 -1,410	-13%	-$291K	0.02%	282
2025 Q3	$2.08M	Buy	10,475 +722	+7%	+$135K	0.02%	271
2025 Q2	$1.68M	Buy	9,753 +803	+9%	+$131K	0.02%	270
2025 Q1	$1.39M	Buy	8,950 +575	+7%	+$82.1K	0.02%	278
2024 Q4	$1.15M	Buy	+8,375	New	+$1.1M	0.01%	284

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital International Inc's ASND Position: Q2 2026 in Review

Capital International Inc increased its Ascendis Pharma A/S (ASND) stake by 0.48% in Q2 2026, buying an estimated $11.7K and bringing the position to 10,443 shares worth $2.79M. The position accounts for 0.02% of the portfolio, ranked #261.

Capital International Inc first reported a position in ASND in Q4 2024 and has held it in 7 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Capital International Inc held 10,443 shares of Ascendis Pharma A/S worth $2.79M as of Q2 2026.
Capital International Inc bought 50 Ascendis Pharma A/S shares in Q2 2026, an estimated $11.7K.
Ascendis Pharma A/S made up 0.02% of Capital International Inc's portfolio in Q2 2026, its #261 holding.
Capital International Inc first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 7 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.